Private Equity

As a veteran leader retires after five years of growth, Husky Technologies brings in Tracy Cordes to spearhead a new era of service innovation.

The iconic brand is pivoting from its print legacy to a diversified lifestyle empire, and it has a new plan to convince investors it's the right move.

Align Partners launches a major governance overhaul campaign at Dentium, aiming to fix the 'Korea discount' and unlock value at the undervalued market leader.

Enhabit and Encompass Health collect millions in damages after a court found former execs committed 'egregious breaches of loyalty' to form a rival.

A landmark $250M royalty financing deal aims to transform i-80 Gold into a major Nevada producer, signaling a massive bet on ambitious, long-term growth.

Gilat DataPath will supply advanced, combat-proven SATCOM terminals to a European MoD, marking a key expansion in the region's push for digital sovereignty.

Restaurant Brands International reports strong 2025 results, fueled by booming international sales, but faces headwinds with Popeyes' slump and BK franchisee pressures.

The newly rebranded firm touts record fundraising and a key acquisition, but declining non-GAAP earnings reveal a more complicated financial reality for investors.

The dominant force in Democratic tech is sending experts into the field, blending digital tools with in-person support to reshape grassroots organizing.

A new report reveals a 17% gender pay gap in Türkiye's fashion sector, driven by systemic issues, not unequal pay for equal work. What does this mean for your clothes?

The Swiss watchmaker partners with the BTS star, leveraging the 'K-Pop effect' in a strategic move to redefine luxury for a new generation.

Aircraft leasing giant Avolon posts record profits, capitalizing on soaring travel demand and severe aircraft shortages plaguing global airlines.

Private equity giants Blackstone and EQT acquire waste management leader Urbaser, highlighting a major bet on the future of the circular economy.

The vaccine maker posts record 2025 earnings on mpox demand but signals a strategic shift, prioritizing its travel vaccine portfolio over new R&D.

The French biopharma giant posts strong 2025 results and forecasts over 13% growth, fueled by a booming pipeline and unexpected market advantages.

New data reveals Mesoblast's cell therapy Ryoncil dramatically boosts survival in GvHD patients when used early, paving the way for a major adult trial.

Private equity firm Clairvest Group reports a 9% book value surge, driven by lucrative sales of F12.net and Acera, while acquiring a major US racino.

The Hong Kong contractor raised nearly $32M in a private placement, a strategic move to fund growth in a booming market that comes at a high cost to investors.

With the hire of elite dealmaker George F. Schoen, the building materials giant is signaling a new era of aggressive M&A and strategic consolidation.

Mizuho Americas and Pursuit launch the AI Nonprofit Build Corps, a new program training diverse talent to bring critical AI skills to NYC's social sector.